Trump Administration Mandates Disclosure of Pharmacy Benefit Manager Fees

Source Summary

A new federal rule from the Trump administration will require pharmacy benefit managers to publicly disclose fees and compensation details that have previously remained confidential. The regulation aims to increase transparency in the prescription drug supply chain by revealing payments currently kept private between middlemen and other parties.

Why it matters

Increased transparency in pharmacy benefit manager payments could affect drug pricing, insurance costs, and how prescription medications are distributed to consumers.